CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,235 enrolled
Drug / intervention
BreastCAREother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01830933
NCT01830933N/ACompleted

Breast Cancer Risk Reduction: A Patient Doctor Intervention

University of California, San Francisco·interventional·Posted Apr 12, 2013·Updated Aug 19, 2014

In Brief

A clinical study evaluating BreastCARE for Breast Cancer. Completed, enrolled 1,235 participants across 2 sites.

Detailed Summary

The proposed research combines the scientific advances in breast cancer research with health information technology (IT) to design a personalized intervention that assesses breast cancer risk for women, disseminates important breast health information, and facilitates discussion of breast cancer risk reduction practices. Our goal is to implement a tablet-PC (personal computer) based breast cancer risk education (BreastCare) intervention in the primary care setting that estimates a woman's individual risk for breast cancer and provides her and her physician with personalized breast cancer risk information and recommendations for action.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 12, 2013
Enrollment StartJun 1, 2011
Primary CompletionAug 1, 2012
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.2 years ago

Interventions

BreastCAREother

Physician Report. At the time of an individual participant's visit to her primary care physician and her completion of the assessment tool, her physician will receive a physician report. The physician report is designed to facilitate communication about breast cancer risk during the primary care visit and to provide tailored risk reduction recommendations.